J1-1 is an inhibitor of ICMT with an IC50 of 1.0 μM and has anticancer activity[1].
References
[1] Yang WS et al. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents. Amino Acids. 2017 Sep;49(9):1469-1485. DOI:10.1007/s00726-017-2454-x